At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01061 ESSEX BIO-TECH
Market Closed 11-15 16:08:33
2.630
+0.000
0.00%
High2.630
Low2.500
Vol121.00K
Open2.520
D1 Closing2.630
Amplitude4.94%
Mkt Cap1.49B
Tradable Cap1.49B
Total Shares567.54M
T/O305.51K
T/O Rate0.02%
Tradable Shares567.54M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Essex Bio-Technology's (HKG:1061) earnings trajectory could turn positive as the stock surges 19% this past week
Essex Bio-Technology Limited is an investment holding company principally engaged in the manufacture and sales of biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The Company develops biopharmaceutical drugs based on recombinant deoxyribonucleic acid (DNA) technology. The main brands of the Company's products are Beifuji, Beifushu and Beifuxin. The Company operates through two business segments. The Pharmaceutical Products segment is engaged in the development, manufacture and sales of pharmaceutical products. The Provision of Marketing Services segment is involved in the distribution of third party products and provision of marketing services to such third party’s products.